Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 94

Results For "PATH"

1241 News Found

50% of the world's population expected to be myopic by 2050
News | May 23, 2022

50% of the world's population expected to be myopic by 2050

Researchers have found out that myopia often leads to an abnormal increase in axial length. When the axial length grows to more than 25mm, especially with age, problems like cataracts or glaucoma can appear


Novartis Cosentyx receives positive CHMP opinion for use in childhood arthritic conditions
Biotech | May 21, 2022

Novartis Cosentyx receives positive CHMP opinion for use in childhood arthritic conditions

Positive opinion could expand the role of Cosentyx (secukinumab) in reducing flare risk in pediatric enthesitis-related arthritis (ERA) and psoriatic arthritis (PsA) patients in the EU


Sparsh Hospital introduces ‘Infinite care’ joint replacement programme
Hospitals | May 20, 2022

Sparsh Hospital introduces ‘Infinite care’ joint replacement programme

‘Infinite Care’ comprises two key pillars - Sparsh Sankalpa and Sparsh Sukshema


Bristol Myers Squibb highlights progress in treatment for cancer and blood disorders
Biotech | May 20, 2022

Bristol Myers Squibb highlights progress in treatment for cancer and blood disorders

First disclosure from PILOT study of Breyanzi in second-line large B-cell lymphoma underscores important role of cell therapy earlier in treatment paradigm


Olympus announces exclusive U.S. co-marketing agreement with Bracco Diagnostics
Medical Device | May 20, 2022

Olympus announces exclusive U.S. co-marketing agreement with Bracco Diagnostics

The partnership will further strengthen Olympus leadership in the diagnosis and staging of liver disease


Propanc Biopharma undertaking PRP manufacturing & development for human use
Biotech | May 20, 2022

Propanc Biopharma undertaking PRP manufacturing & development for human use

PRP is a mixture of two proenzymes, trypsinogen and chymotrypsinogen from bovine pancreas administered by intravenous injection


Grand Opening of Kodiak Sciences’ bioconjugation facility
Biotech | May 19, 2022

Grand Opening of Kodiak Sciences’ bioconjugation facility

Purpose-built bioconjugation facility in Lonza’s Ibex Dedicate Biopark in Visp, Switzerland to support the potential commercial launch of Kodiak's lead product candidate KSI-301 for high-prevalence retinal diseases


Janssen’s icare4u to assist people living with skin, joint and digestive disorders
Healthcare | May 19, 2022

Janssen’s icare4u to assist people living with skin, joint and digestive disorders

The icare4u program features a dedicated website, with comprehensive information about the diseases, videos with medical experts, and a social media community for patients and caregivers on Facebook and YouTube


Agilent companion diagnostic expands CE-IVD Mark in Europe to include cervical cancer
Medical Device | May 18, 2022

Agilent companion diagnostic expands CE-IVD Mark in Europe to include cervical cancer

Globally, cervical cancer is the fourth most common cancer among women, with approximately 30,447 new cases diagnosed in Europe in 2020


Innovative AI software for detection of pancreatic diseases
Digitisation | May 18, 2022

Innovative AI software for detection of pancreatic diseases

As part of large-scale clinical studies prior to market introduction, the AI software has now gone into clinical test with patients, so-called first-in-human applications